TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario



Michael Stinson

Michael Stinson was appointed Executive Director of TBI in June 2008. In addition to his role as Executive Director, Michael is also a member of the TBI Executive Committee.

Since 2001, Michael has been executive director of BioFinance Canada where his role was to develop the sponsor base, increase the number and quality of presenting companies, and to increase the number of attendees at each conference.

In previous assignments, Michael was president of CTD Clinical Trial Developments Inc., a spin out of Endpoint Research Ltd., which provided research management services to hospital research departments for Phase II and Phase III clinical trials. As a consultant, he conducted market and investment research for a variety of public and private sector clients including: Medical Research Council, Industry Canada, Canadian Institutes of Health Research, Department of Foreign Affairs & International Trade, and various private clients. He also published: Canadian Biotechnology Status of Research and Clinical Trials, Directory of Canadian Clinical Research Facilities and the Directory of Canadian Pharmaceutical Manufacturing Industry.

He began his career as a trade commissioner in trade and investment for Technologies for the Canadian Department of Foreign Affairs with assignments from 1974 to 1998 in Beirut, Sydney, Rio de Janeiro, Amman, Yokohama, Tokyo and San Diego. He has a BA in Economics from the University of Western Ontario and an MBA from the University of Toronto.